Description
Letrozole, sold as Femara, is a non-steroidal aromatase inhibitor generally regarded as one of the more potent reversible inhibitors of the class.
Letrozole in brief
A third-generation, non-steroidal aromatase inhibitor. LETROZOLE Xeno Labs is the named manufacturer for this listing. This item is filed under pct.
Specifications
| Spec | Value |
|---|---|
| Compound | Letrozole (Femara) |
| CAS number | 112809-51-5 |
| Manufacturer | LETROZOLE Xeno Labs |
Notes
Letrozole and anastrozole are both non-steroidal, reversible aromatase inhibitors, differing mainly in potency and dosing rather than mechanism.
Legal status
Letrozole is a Class C controlled substance in the UK under the Misuse of Drugs Act 1971. It is not a licensed human medicine and is treated as prescription-only where used clinically. This page is research and reference material only; the UK Government’s FRANK service sets out the law. No medical or performance claims are made, and dosing belongs with a qualified professional.
Frequently asked questions
Is Femara the same as letrozole? Yes, Femara is the trade name for letrozole.
How does letrozole differ from anastrozole? Both are non-steroidal reversible aromatase inhibitors; letrozole is generally regarded as more potent.
Is letrozole a SERM? No, it is an aromatase inhibitor, not a selective oestrogen receptor modulator.
Is letrozole legal in the UK? It is a prescription-only medicine and is not a controlled substance under the Misuse of Drugs Act 1971; this listing is a research reference item.




Reviews
There are no reviews yet.